Бібліотека Вінницького національного медичного університету ім. М.І.Пирогова

Главная

Упрощенный режим

Видео-инструкция

Описание

Базы данных

Периодические издания- результаты поиска

Вид поиска

Книги

Периодические издания

Область поиска

Формат представления найденных документов:
полный	информационный	краткий

Отсортировать найденные документы по:
автору	заглавию	году издания	типу документа

Поисковый запрос: (<.>A=Buchynska, L. G.$<.>)

Общее количество найденных документов : 20
Показаны документы с 1 по 20

Шифр: ЕУ12/2006/28/2
Журнал

Экспериментальная онкология [Текст]
2006г. Т. 28 № 2

Содержание:
Georgolios, A. The role of CD44 adhesion molecule in oral cavity cancer / A. Georgolios [и др.] . - С.94-98
Другие авторы: Batistatou A., Charalabopoulos A., Manolopoulos L., Charalabopoulos K.
McShane, L. M. Reporting recommendations for tumor marker prognostic studies (remark) / L. M. McShane [и др.] . - С.99-105
Другие авторы: Altman D.G., Sauerbrei W., Taube S.E., Gion M., Clark G.M.
Xu, G. Antitumor activities of the four sesquiterpene lactones from ELEPHANTOPUS SCABER L / G. Xu [и др.] . - С.106-109
Другие авторы: Liang Q., Gong Z., Yu W., He S., Xi I.
Kyyamova, R. G. Expression of SSX2 tumor antigen in baculovirus expression system and its application for screening of blood serum of melanoma patients / R. G. Kyyamova [и др.] . - С.110-113
Другие авторы: Gryshkova V.S., Zhyvoioup A.M., Korovin S.I., Gout I.T., Filonenko V.V.
Olishevsky, S. Modulation of ros/no production by murine peritoneal macrophages in responseto bacterial CPG DNA stimulation / S. Olishevsky [и др.] . - С.114-120
Другие авторы: Burlaka A., Sidorik E., Shiyakhovenko V., Garpenko Yu., Kozak V.
Karkabounas, S. Anticarcinogenic and antiplatelet effects of carvacrol / S. Karkabounas [и др.] . - С.121-125
Другие авторы: Kostoula O.K., Daskalou T., Veltsistas P., Karamouzis M., Zelovitis I., Metsios A.
Hao, S. Epigenetic transfer of metastatic activity by uptake of highly metastatic B 16 melanoma cell-released exosomes / S. Hao [и др.] . - С.126-131
Другие авторы: Ye Z., Meng Q., Qureshi M., Yang J., Xiang J.
Shlyakhovenko, V. Application of dna from mushroom pleurotus ostreatus for cancer biotherapy: a pilot study / V. Shlyakhovenko, V. Kosak, S. Olishevsky. - С.132-135
Lu, Y. Gene therapeutic treatment of pancreatic cancer based on injection of pcDNA3.1/CCK plasmid with xenogeneic homologous cholecystokinin / Y. Lu, J. -G. Bai, H. -H. Wang. - С.136-140
Arumugam, G. Effect of gallium nitrate on tamoxifen induced hypercalcemia in rats bearing mammary tumor / G. Arumugam, P. Shanthi, P. Sachdanandam. - С.141-145
Isaikina, Y. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro / Y. Isaikina, A. Kustanovich, A. Svirnovski. - С.146-151
Buchynska, L. G. Expression of the cell cycle regulators p53, p21{\up WAF1/CIP1} and p-16 {\up INK4A} in human endometrial adenocarcinoma / L. G. Buchynska, I. P. Neslna. - С.152-155
Romanowicz-Makowska, H. Analysis of RAD51 polymorphism and BRCA 1 mutations in polish women with breast cancer / H. Romanowicz-Makowska [и др.] . - С.156-159
Другие авторы: Smolarz B., Zadrowy M., Kulig A.
Prylutska, S. V. Effect of the visible light irradiation of fullerene-containing composites on the ros generation and the viability of tumor cells / S. V. Prylutska [и др.] . - С.160-162
Другие авторы: Burlaka A.P., Matyshevska O.P., Golub A.A., Potebnya G.P., Prylutskyy Y.I., Ritter U., Scharff P.
Baran, Y. Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine / Y. Baran, V. Gunduz, A. U. Ural. - С.163-165
Glushkov, A. N. Immunological images of polycyclic aromatic hydrocarbons / A. N. Glushkov [и др.] . - С.166-168
Другие авторы: Kostyanko M.V., Anosava T.P., Polenok E.G., Mun S.A., Anosov M.P., Cherno S.V.
Bugdayci, G. Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer / G. Bugdayci [и др.] . - С.169-171
Другие авторы: Kaplan T., Sezer S., Turban T., Koca Y., Kocer D., Yildirim E.
Gluzman, D. F. Structure of leukemias and lymphomas in children of Ukraine in post-chernobyl period / D. F. Gluzman [и др.] . - С.172-174
Другие авторы: Sklyarenko L.M., Nadgornaya V.A., Zavelevich M.P., Poludnenko L.Yu., Ivanwskaya T.S., Koval S.V., Simonet M.-L.
Имеются экземпляры в отделах: всего 1
Свободны: 1

Найти похожие

Buchynska, L. G.
Expression ofthe cell cycle regulators p53, p21{\up WAF1/CIP1} and p-16 {\up INK4A} in human endometrial adenocarcinoma [Текст] = Особенности экспрессии регуляторов клеточного цикла p53, p21{\up WAF1/CIP1} and p-16 {\up INK4A} аденокарциномах эндометрия человека / L. G. Buchynska, I. P. Neslna // Экспериментальная онкология. - 2006. - Т. 28, № 2. - С. 152-155

Рубрики: Эндометрия новообразования

Доп.точки доступа:
Neslna, I. P.

Найти похожие

Шифр: ЕУ12/2019/41/4
Журнал

Экспериментальная онкология [Текст]
2019г. Т. 41 № 4 . - 45.41, р.

Содержание:
Karaman, O. M. Macrophages - a perspective target for antineoplastic immunotherapy / O. M. Karaman, A. V. Ivanchenko, V. F. Chekhun. - С.282-290
Orel, V. E. Nоn-linear dynamics theory and malignant melanoma / V. E. Orel [et al.]. - С.291-299
Другие авторы: Korovin S. I., Molnair J., Orel V. B.
Lisyany, N. I. Cytomegaloviruses and malignant brain tumors / N. I. Lisyany [et al.]. - С.300-303
Другие авторы: Klyuchnikova A. A., Belskaya L. N., Lisyany A. A., Gnedkova I. A.
Woksepp, H. Proteomics of transforming growth factor β1 (TGF β1) signaling in 184A1 human breast epithelial cells suggests the involvement of casein kinase 2α in TGF β1-dependent p53 phosphorylation at Ser392 / H. Woksepp [et al.]. - С.304-311
Другие авторы: Saini R. K. R., Zakharchenko O., Gautier A., Souchelnytskyi N., Souchelnytskyi S.
Dehghan, Nayeri M. J. Apoptosis-inducing effect of spiroaminopyrimidine analogue in NB 4 leukemia cells via down-regulation of BIRC5 expression / Nayeri M. J. Dehghan [et al.]. - С.312-317
Другие авторы: Mahdavi M., Fazeli H., Hosseinpour Feizi M. A.
Albuquerque, A. P. B. Fut3 expression in human breast cancer cells under hypoxia and serum deprivation / A. P. B. Albuquerque [et al.]. - С.318-322
Другие авторы: Silva A. L. V., Lima C. A. D., Beltrao E. I. C.
Skuja, E. Deletions in metastatic colorectal cancer with chromothripsis / E. Skuja [et al.]. - С.323-327
Другие авторы: Butane D., Nakazawa-Miklasevica M., Daneberga Z., Purkalne G., Miklasevics E.
Burlaka, A. P. Molecular mechanisms of oxidation damage and liver cell dysfunction in patients with metastatic colorectal cancer / A. P. Burlaka [et al.]. - С.328-334
Другие авторы: Burlaka A. A., Virko S. V., Ganusevich I. I.
Buchynska, L. G. Morphological characteristics and expression of adhesion markers in cells of low differentiated endometrial carcinoma / L. G. Buchynska, L. A. Naleskina, I. P. Nesina. - С.335-341
Zelinskaya, A. Immunocytochemical characteristics of thyrocytes in radioiodine refractory metastases of papillary thyroid cancer / A. Zelinskaya. - С.342-345
Moazeni-Roodi, A. Association bewtween XPO5 rs 1 1077 polymorphism and cancer susceptibility: a meta-analysis of 7284 cases and 85 1 1 controls / A. Moazeni-Roodi, M. Taheri, M. Hashemi. - С.346-352
Skrypnyk, I. How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy / I. Skrypnyk [et al.]. - С.353-356
Другие авторы: Maslova G., Lymanets T., Gusachenko I.
Gavars, D. Association of elevated vitamin B12 with oncohematological diseases in a cohort of 79, 524 patients from Lanvia / D. Gavars [et al.]. - С.357-362
Другие авторы: Perminov D., Tauckels E., Lindenberga I., Auce A., Lejniece S.
Prylutskyi, M. P. Detection of polyamines using immunobiosensor based on zinc oxide nanoparticles / M. P. Prylutskyi, M. F. Starodub. - С.363-365
Shkatula, P. M. International scientific conference "Tumor and Host: novel aspects of old problem" / P. M. Shkatula. - С.366-367
To the 120th birthday anniversary of academician R. E. Kavetsky. - С.368-369
Имеются экземпляры в отделах:
Экз. 1 (свободен)

Найти похожие
Перейти к описаниям статей

Buchynska, L. G.
Morphological characteristics and expression of adhesion markers in cells of low differentiated endometrial carcinoma / L. G. Buchynska, L. A. Naleskina, I. P. Nesina // Experimental Oncology. - 2019. - Том 41, N 4. - P335-341

Аннотация: The aim of the study was to evaluate the morphological features of endometrioid carcinoma of the endometrium (ECE) of low differentiation grade with different invasive potential and to characterize their molecular phenotype by the expression of a number of adhesion markers. Materials and Methods: We have studied the samples of operation material of 37 patients with ECE of low differentiation grade with deep invasion ( ½ myometrium), n = 26, and with invasion ½ myometrium, n
Доп.точки доступа:
Naleskina, L. A.
Nesina, I. P.

Свободных экз. нет

Найти похожие

Шифр: ЕУ12/2018/40/4
Журнал

Экспериментальная онкология [Текст]
2018г. Т. 40 № 4

Содержание:
Oncology in the mainstream of the National academy of sciences of Ukraine: to the 100th anniversary of the academy / ed. V. F Chekhun. - С.258-260
Tari, K. The role of the genetic abnormalities, epigenetic and microRNA in the prognosis of chronic lymphocytic leukemia / K. Tari [et al.]. - С.261-267
Другие авторы: Shamsi Z., Ghafari H. R., Atashi A., Shahjahani M., Abroun S.
Chekhun, V. F. Influence of ferromagnetic nanocomposite (ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism / V. F. Chekhun [et al.]. - С.268-274
Другие авторы: Todor I. N., Lukianova N. Yu., Horbyk D. M., Lozovskaya Yu. V., Burlaka A. P., Borikun T. V.
Symchych, T. V. The effects of early postoperative immunization with xenogeneic embryo proteins on Lewis lung carcinoma model / T. V. Symchych [et al.]. - С.275-281
Другие авторы: Fedosova N. I., Karaman O. M., Voyeykova I. M., Didenko G. V.
Yakymenko, I. Oxidative and mutagenic effects of low intensity GSM 18OO MHz microwave radiation / I. Yakymenko [et al.]. - С.282-287
Другие авторы: Burlaka A., Tsybulin O., Brieieva O., Buchynska L., Tsehmistrenko S., Chekhun V.
Smal, M. P. Ber gene polymorphisms associated with key molecular events in bladder cancer / M. P. Smal [et al.]. - С.288-298
Другие авторы: Kuzhir T. D., Savina N. V., Nikitchenko N. V., Rolevich A. I., Krasny S. A., Goncharova R. I.
Abooshahab, R. Serum level dipeptidyl peptidase-4 as a potential biomarker for medullary thyroid cancer / R. Abooshahab [et al.]. - С.299-302
Другие авторы: Niyazi E., Yaghmaie P., Chadaksaz H. G., Hedayati M.
Buchynska, L. G. Overexpression of the mitochondrial ribosomal protein S 18-2 in the invasive breast carcinomas / L. G. Buchynska [et al.]. - С.303-308
Другие авторы: Iurchenko N. P., Kashuba E. V., Brieieva O. V., Glushchenko N. M., Mints M., Lukianova N. Yu., Chekhun V. F.
Arabpour, F. FoxP3 gene polymorphism is associated with breast cancer in iranian patients / F. Arabpour [et al.]. - С.309-314
Другие авторы: Shafizad A., Rahimzadeh M., Norouzian M., Naderi N.
Gerashchenko, G. V. Expression pattern of genes associated with tumor microenvironment in prostate cancer / G. V. Gerashchenko [et al.]. - С.315-322
Другие авторы: Grygoruk O. V., Kononenko O. A., Gryzodub O. P., Stakhovsky E. O., Kashuba V. I.
Tas, F. Clinical significance of serum caveolin-1 levels in gastric cancer patients / F. Tas [et al.]. - С.323-327
Другие авторы: Karabulut S., Erturk K., Duranyildiz D.
Shvachko, L. P. Vitamin E activates expression of C/EBP alpha transcription factor and G-CSF receptor in leukemic K562 cells / L. P. Shvachko [et al.]. - С.328-331
Другие авторы: Zavelevich M. P., Gluzman D. F., Kravchuk I. V., Telegeev G. D.
Kuzyk, P. V. Rare case of nodular lymphoid hyperplasia of left lung in the patient with previous pulmonary tuberculosis / P. V. Kuzyk, M. A. Savchyna, S. G. Gychka. - С.332-335
Zakhartseva, L. M. Metastatic cardiac tumors: literature review and own observation of testicular tumor metastasis in the right ventricle of the heart / L. M. Zakhartseva [et al.]. - С.336-342
Другие авторы: Zakharova L. P., Shatrova K. M., Chitaeva G. E., Vitovsky R. M.
Langabeer, S. E. The JAK2 V617F mutation in lung cancer: caveat emptor / S. E. Langabeer. - С.343-344
Professor Volodymyr Oleksiiovych Shlyakhovenko (on the 80th birth anniversary). - С.345
Имеются экземпляры в отделах:
Экз. 1 (свободен)

Найти похожие
Перейти к описаниям статей

Overexpression of the mitochondrial ribosomal protein S 18-2 in the invasive breast carcinomas / L. G. Buchynska [et al.] // Experimental Oncology. - 2018. - Том 40, N 4. - P303-308

MeSH-главная:
МОЛОЧНОЙ ЖЕЛЕЗЫ НОВООБРАЗОВАНИЯ -- BREAST NEOPLASMS (диагностика, метаболизм, патофизиология)
ВНУТРИКЛЕТОЧНЫЕ СИГНАЛЬНЫЕ ПЕПТИДЫ И БЕЛКИ -- INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS (метаболизм)
Аннотация: Recent studies allow to consider the mitochondrial ribosomal protein S18-2 (MRPS18-2, S18-2) as a potential oncoprotein, which suggests the need for further characterization of its expression in tumors of different genesis including breast cancer (BC). The aim of the study was to analyze the expression of the S18-2 protein in BC of luminal A and basal subtypes. Materials and Methods: Operational material of BC patients stage І–ІІ (luminal A subtype, n = 30, and basal subtype, n = 10) was studied with the use of morphological, immunohistochemical, statistical and bioinformatic methods. Results: Using the immunohistochemical analysis, we found that the S18-2 protein showed the nuclear signal in 66.7% of luminal A subtype BC samples and 80.0% of basal subtype BC samples. The variability of the S18-2 expression in both the luminal A and basal subtypes of BC was revealed. Noteworthy, the number of cells expressing S18-2 in high-proliferating tumors of luminal A and basal subtype is significantly higher than in tumors with a low proliferative potential (p 0.05). In 10 samples of luminal A subtype, the nuclear S18-2 signal was higher than median value. Moreover, the S18-2 protein was overexpressed in 4 out of such 10 samples. Metastases in the lymph nodes were found in 3 out of 4 patients with the stage II BC, low differentiation grade of the tumor and high proliferative activity. The bioinformatic analysis confirms our preliminary findings that the trend for increasing expression of the S18-2 protein in tumors correlates with the aggressiveness of malignant BC. Conclusion: The S18-2 protein may be a marker of cancer aggressiveness in BC patients
Доп.точки доступа:
Buchynska, L. G.
Iurchenko, N. P.
Kashuba, E. V.
Brieieva, O. V.
Glushchenko, N. M.
Mints, M.
Lukianova, N. Yu.
Chekhun, V. F.

Свободных экз. нет

Найти похожие

Шифр: ЕУ12/2021/43/2
Журнал

Экспериментальная онкология [Текст]
2021г. Т. 43 № 2

Содержание:
Vitruk, Yu. V. Evaluation of response to tyrosine kinase inhibitors in renal cell carcinoma patients based on expression of miR-99b, -144, -210, -222, -302a and -377 in tumor tissue / Yu. V. Vitruk [et al.]. - С.98-103
Другие авторы: Semko S. L., Voylenko O. A., Pikul M. V., Borikun T. V., Zadvornyi T. V., Yalovenko T. M., Stakhovsky E. O., Rossylna O. V.
Pyaskovskaya, O. N. Role of tumor/endothelial cell interactions in tumor growth and metastasis / O. N. Pyaskovskaya [et al.]. - С.104-110
Другие авторы: Kolesnik D. L., Garmanchouk L. V., Yanish Yu. V., Solyanik G. I.
Akalovich, S. 5-FU resistens colorectal cancer cells possess improved invasiveness and β_III-tubulin expression / S. Akalovich [et al.]. - С.111-117
Другие авторы: Portyanko A., Pundik A., Mezheyeuski A., Doroshenko T.
Bychkov, V. A. In vitro modeling of tumor interclonal interactions using breast cancer cell lines / V. A. Bychkov [et al.]. - С.118-124
Другие авторы: Pevzner A. M., Nebova J. A., Ermakova N. N., Ibragimova M. K., Tsyganov M. M., Lyapunova L. S., Litviakov N. V.
Ayyildiz, A. Co-administration of apigenin with doxorubicin enhanges anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells / A. Ayyildiz [et al.]. - С.125-134
Другие авторы: Koc H., Turkekul K., Erdogan S.
Buchynska, L. G. Expression of chemokine receptor CXCR4 in tumor cells and content of CXCL12+ -fibroblasts in endometrioid carcinoma of endometrium / L. G. Buchynska, O. M. Movchan, N. P. Iurchenko. - С.135-141
Yakovlev, P. G. Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage / P. G. Yakovlev [et al.]. - С.142-148
Другие авторы: Gorbach O. I., Ostapchenko L. I., Garmanchuk L. V., Skachkova O. V., Khranovska N. M., Senchylo N. V.
Zoubi, M. S. RAD51-UTR haplotype genetic polymorphisms and susceptibility to breast cancer in women from Jordanian population / M. S. Zoubi [et al.]. - С.149-154
Другие авторы: Al-Eitan L. N., Rababa D. M., Al-Batayneh K., Farzand R., Quinn G. A., Tambuwala M. M., Bakshi H. A.
Kornatska, A. G. A variant of TP53 gene (RS 1625895, 13494G>A) is associated with neoplasm localization in patients with uterine leiomyoma / A. G. Kornatska [et al.]. - С.155-158
Другие авторы: Flaksemberg M. A., Chubei G. V., Trokhymovych O. V., Rossokha Z. I., Fishchuk L. Ye., Medvedieva N. L., Vershyhora V. O., Gorovenko N. G.
Mohamed, Yusoff A. A. Significance of BRAFv600E mutation in intra-axial brain tumor in Malaysian patients: case series and literature review / A. A. Mohamed Yusoff [et al.]. - С.159-167
Другие авторы: Abd Radzak S. M., Mohd Khair S. Z. N., Abdullah J. M.
Ben, Kridis W. Therapeutic results of laryngeal preservation: a retrospective study / W. Ben Kridis [et al.]. - С.168-172
Другие авторы: Werda I., Mnejja W., Toumi N., Charfeddine I., Daoud J., Khanfir A.
Pilinska, M. A. Study of modifyng effects of astaxanthin on cytogenetic manifestations of bystander response in human peripheral blood lymphocytes in vitro / M. A. Pilinska [et al.]. - С.173-176
Другие авторы: Shemetun O. V., Talan O. O., Dibska O. B., Talko V. V.
De, Giorgi V. Scrotal cutaneous metastasis from rectal squamous cell carcinoma: a rare evolution into a rare tumor / V. De Giorgi [et al.]. - С.177-179
Другие авторы: Venturi F., Portelli F., Maida P., Scarfi F., Trane L., Gori A., Silvestri F., Massi D.
Liubota, R. Systemic chemotherapeutic treatment of patients with breast cancer brain metastases / R. Liubota [et al.]. - С.180-184
Другие авторы: Vereshchako R., Anikusko M., Liubota I., Vakulenko G.
Pasichnyk, S. M. Predicting changes in glomerular filtration rate in patients with kidney cancer using a mathematical model / S. M. Pasichnyk [et al.]. - С.185-188
Другие авторы: Pasichnyk M. S., Lychkovsky A. E., Stakhovsky E. O., Gozhenko A. I., Shatnyi S. V., Pasichnyk M. A.
Gluzman, D. F. Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects / D. F. Gluzman [et al.]. - С.189-192
Другие авторы: Zavelevich M. P., Philchenkov A. A., Koval S. V., Guslitser L. N., Zinchenko V. N., Bezhenar T. O.
Имеются экземпляры в отделах:
(23.05.2022г. Экз. 1 - Б.ц.) (свободен)

Найти похожие
Перейти к описаниям статей

Buchynska, L. G.
Expression of chemokine receptor CXCR4 in tumor cells and content of CXCL12+ -fibroblasts in endometrioid carcinoma of endometrium [Text] / L. G. Buchynska, O. M. Movchan, N. P. Iurchenko // Experimental Oncology. - 2021. - Том 43, N 2. - P135-141

MeSH-главная:
КАРЦИНОМА ЭНДОМЕТРИОИДНАЯ -- CARCINOMA, ENDOMETRIOID (лекарственная терапия, метаболизм, патофизиология)
Аннотация: The expression of the CXCL12 chemokine and its receptor CXCR4 in the stromal component of the tumor plays an important role in tumor cell migration, proliferation, inhibition of apoptosis and determination of invasive and metastatic potential of malignant neoplasms of various genesis. The significance of CXCL12 and CXCR4 expression in endometrial tumor cells for cancer progression is not fully understood. Aim: To evaluate the content of CXCL12+-fibroblasts and expression of CXCL12 and CXCR4 in endometrial cancer cells, depending on the tumor stage. Materials and Methods: Surgical material of 45 patients with endometrioid carcinoma of the endometrium (ECE) of the stages I–II and III was studied using morphological and immunohistochemical methods. Results: In ECE of stage I–II CXCR4 expression was lower (43.3 ± 4.2%) while CXCL12 expression was higher (33.6 ± 2.4%) compared with the corresponding indices in ECE of stage III (63.6 ± 3.5%, 24.5 ± 1.9%, respectively, p 0.05). In ECE of stage III, high expression of CXCR4 ( Me) and low CXCL12 ( Me) was observed in 80% of samples; these tumors invaded more than 1/2 of the myometrium. There was a positive correlation between the depth of tumor invasion in the myometrium and the presence of metastases and CXCR4 expression in tumor cells (R Me) (14.9 ± 1.3%) was detected. Conclusion: The obtained data reflect the communication of the immunosuppressive factor of the tumor microenvironment, i.e. CXCL12+-fibroblasts and CXCR4 expressing tumor cells. We suggest that the aggressiveness of ECE is determined by the combined effect of these two factors
Доп.точки доступа:
Movchan, O. M.
Iurchenko, N. P.

Свободных экз. нет

Найти похожие

Шифр: ЕУ12/2017/39/4
Журнал

Экспериментальная онкология [Текст]
2017г. Т. 39 № 4 . - 34.76, р.

Содержание:
Liubich, L. D. TGF-β1 expression by glioma C6 cells in vitro / L. D. Liubich [та ін.]. - С.258-263. - Bibliogr. at the end of the art.
Другие авторы: Kovalevska L. M., Lisyany M. I., Semenova V. M., Malysheva T. A., Stayno L. P., Vaslovych V. V.
Pyaskovskaya, O. N. Cytotoxic activity of metformin in vitro does not correlate with its antitumor action in vivo / O. N. Pyaskovskaya [та ін.]. - С.264-268. - Bibliogr. at the end of the art.
Другие авторы: Kolesnik D. L., Fedorchuk A. G., Gorbik G. V., Solyanik G. I.
Herrera-Covarrubias, D. Stress during puberty facilitates precancerous prostate lesions in adult rats / D. Herrera-Covarrubias [та ін.]. - С.269-275. - Bibliogr. at the end of the art.
Другие авторы: Coria-Avila G. A., Hernandez M. E., Ismail N.
Caballero-Hernandez, D. Alterations of antitumor and metabolic responses in L5178Y-R lymphoma-bearing mice after only 30-minute daily chronic stress exposure / D. Caballero-Hernandez [та ін.]. - С.276-280. - Bibliogr. at the end of the art.
Другие авторы: Najera-Valderrabano D., Valadez-Lira A., Franco-Molina M., Gomez-Flores R., Tamez-Guerra P., Tamez-Guerra R., Rodriguez-Padilla C.
Bebeshko, V. Assessment of the effect of wave device application on morphological changes in organs and cells of irradiated animals / V. Bebeshko, I. Homolyako, V. Grynchyshyn. - С.281-285. - Bibliogr. at the end of the art.
Matveeva, A. The TGF-beta — SMAD pathway is inactivated in cronic lymphocytic leukemia cells / A. Matveeva [та ін.]. - С.286-290. - Bibliogr. at the end of the art.
Другие авторы: Kovalevska L., Kholodnyuk I., Ivanivskaya T., Kashuba E.
Gordiienko, I. M. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells / I. M. Gordiienko, L. M. Shlapatska, V. M. Kholodniuk. - С.291-298. - Bibliogr. at the end of the art.
Buchynska, L. G. DNA damage in tumor cells and peripheral blood lymphocytes of endometrial cancer patients assessed by the comet assay / L. G. Buchynska [та ін.]. - С.299-303. - Bibliogr. at the end of the art.
Другие авторы: Brieieva O. V., Lurchenko N. P., Protsenko V. V., Nespryadko S. V.
Dumanskiy, Y. V. Adsorption-rheological properties of blood serum in lung cancer patients / Y. V. Dumanskiy [та ін.]. - С.304-307. - Bibliogr. at the end of the art.
Другие авторы: Stoliarova O. Y., Syniachenko O. V., Giulmamedova M. F., Potapov Y. A.
Skrypnyk, I. L-arginine is an effective medication for prevention of endothelial dysfunction a predictor of anthracycline cardiotoxicity in patients with acute leukemia / I. Skrypnyk [та ін.]. - С.308-311. - Bibliogr. at the end of the art.
Другие авторы: Maslova G., Lymanets T., Gusachenko I.
Buchynska, L. G. Phenotypic features of endometrial tumors in patients with family history of cancer / L. G. Buchynska [та ін.]. - С.312-318. - Bibliogr. at the end of the art.
Другие авторы: Lurchenko N. P., Glushchenko N. M., Nesina I. P.
Patial, T. Consumptive hypothyroidism: an unusual paraneoplastic manifestation of a gastric gastrointestinal stromal tumor / T. Patial [та ін.]. - С.319-321. - Bibliogr. at the end of the art.
Другие авторы: Sharma K., Thakur D., Gupta G.
Volodymyr Serhiiovych Mosiienko (1934–2017). - С.322
Имеются экземпляры в отделах: всего 1
Свободны: 1

Найти похожие
Перейти к описаниям статей

10.

DNA damage in tumor cells and peripheral blood lymphocytes of endometrial cancer patients assessed by the comet assay [Текст] / L. G. Buchynska [та ін.] // Экспериментальная онкология. - 2017. - Т. 39, № 4. - С. 299-303. - Bibliogr. at the end of the art.

MeSH-главная:
ЭНДОМЕТРИЯ НОВООБРАЗОВАНИЯ -- ENDOMETRIAL NEOPLASMS (этиология)
ГЕНЫ СУПРЕССОРЫ ОПУХОЛЕВОГО РОСТА -- GENES, TUMOR SUPPRESSOR (физиология)
ДНК ПОВРЕЖДЕНИЕ -- DNA DAMAGE (физиология)
ЛИМФОЦИТЫ, ИНФИЛЬТРИРУЮЩИЕ ОПУХОЛЕВЫЕ КЛЕТКИ -- LYMPHOCYTES, TUMOR-INFILTRATING (ультраструктура)
ПЕНЕТРАНТНОСТЬ -- PENETRANCE
СТАТИСТИЧЕСКАЯ ОБРАБОТКА ДАННЫХ -- DATA INTERPRETATION, STATISTICAL
Аннотация: To date, genome instability is considered to be a common feature not only of tumor cells, but also of non-malignant cells of cancer patients, including peripheral blood lymphocytes (PBLs). The issue of the association between genome instability in tumor cells and PBLs, as well as of its relationship with tumor progression remains poorly understood. Aim: To evaluate the level DNA damage in tumor cells and PBLs of endometrial cancer (EC) patients with regard to clinical and morphological characteristics of the patients. Materials and Methods: DNA damage was assessed in 106 PBLs samples and 42 samples of tumor cell suspension from EC patients by comet assay. PBLs from 30 healthy women were used as control. The level of DNA damage was expressed as the percentage of DNA in the comet tails (% tail DNA). Results: It was revealed that the amount of DNA damage in PBLs of EC patients was 2.2 times higher in comparison with that of healthy donors (8.3 ± 0.7 and 3.7 ± 0.4% tail DNA, respectively) (p 0.05). In this study, no association between the levels of DNA damage in endometrial tumor cells and PBLs was observed (r 0.05). The amounts of DNA damage both in tumor cells and PBLs were not related to the degree of tumor differentiation as well as the depth of myometrial invasion, but depended on the body mass index (BMI) of EC patients: high level of lesions was observed in patients with elevated BMI values. Furthermore, the level of DNA damage in tumor cells was associated to familial aggregation of cancer and was significantly higher in endometrial cells from patients with family history of cancer vs that from EC patients with sporadic tumors (32.3 ± 2.9 and 22.8 ± 1.8% tail DNA, respectively) (p 0.05). It was also found that for women who had high level of DNA damage in PBLs, the risk of EC was greater (odds ratio value of 3.5) compared to those with low level of such lesions. Conclusion: Genome instability that appears as an increased level of DNA damage in tumor cells and PBLs of EC patients is associated with BMI and family history of cancer and can reflect a predisposition to cancer
Доп.точки доступа:
Buchynska, L. G.
Brieieva, O. V.
Lurchenko, N. P.
Protsenko, V. V.
Nespryadko, S. V.

Свободных экз. нет

Найти похожие

11.

Phenotypic features of endometrial tumors in patients with family history of cancer [Текст] / L. G. Buchynska [та ін.] // Экспериментальная онкология. - 2017. - Т. 39, № 4. - С. 312-318. - Bibliogr. at the end of the art.

MeSH-главная:
ЭНДОМЕТРИЯ НОВООБРАЗОВАНИЯ -- ENDOMETRIAL NEOPLASMS (патофизиология, этиология)
ГЕНЕТИЧЕСКАЯ ПРЕДРАСПОЛОЖЕННОСТЬ К БОЛЕЗНИ -- GENETIC PREDISPOSITION TO DISEASE (этиология, этнология)
ФЕНОТИП -- PHENOTYPE
ГЕННОЙ ЭКСПРЕССИИ НОВООБРАЗОВАНИЙ РЕГУЛЯЦИЯ -- GENE EXPRESSION REGULATION, NEOPLASTIC
СТАТИСТИЧЕСКАЯ ОБРАБОТКА ДАННЫХ -- DATA INTERPRETATION, STATISTICAL
ФОТОГРАФИЧЕСКИЕ СНИМКИ -- PHOTOGRAPHS
Аннотация: To determine the peculiarities of expression of a number of proteins-regulators of the cell cycle in endometrial cancer (EC) cells in patients with a family history of oncological pathologies. Patients and Methods: 95 EC patients (stage І–ІІ) were included into the study. Clinical-genealogical analysis was performed. 54 patients (group I) had healthy relatives, and in families of 41 patients (group II) an aggregation of malignant tumors of different genesis (mainly tumors of the gastrointestinal tract and the female reproductive system) was recorded. p53, р21WAF1/CIP1, р16INK4a, and Ki-67 were assessed immunohistochemically in the surgical samples. Results: In the majority of patients, both from group I and II, moderately differentiated tumors were observed (in 38.9 and 46.3% of cases, respectively), mainly with deep myometrium invasion (64.8 and 58.5% of cases, respectively). In EC patients from group II, a significantly higher number of р16INK4a-positive cells (17.7 ± 1.7%; p = 0.001) and lower number of p53-positive (30.9 ± 3.2%; p = 0.05) and Ki-67-positive (26.9 ± 2.7%; p = 0.048) cells was observed compared to those in tumors of patients from group I (12.0 ± 1.6; 37.7 ± 2.8 and 36.7 ± 3.4%, respectively). Conclusion: Phenotypic features of the EC in the patients with family history of cancer differ from those in tumors of patients without such aggregation. The biological heterogeneity of EC seems to relate to the oncogenealogical history of patients. Also this biological heterogeneity is linked to the molecular features of EC cells, which affects cancer aggressiveness and the course of the disease
Доп.точки доступа:
Buchynska, L. G.
Lurchenko, N. P.
Glushchenko, N. M.
Nesina, I. P.

Свободных экз. нет

Найти похожие

12.

Шифр: ЕУ12/2018/40/1
Журнал

Экспериментальная онкология [Текст]
2018г. Т. 40 № 1

Содержание:
Kian, R. Role of components of microRNA machinery in carcinogenesis / R. Kian, S. Moradi, S. Ghorbian. - С.2-9. - Bibliogr. at the end of the art.
Patel, K. R. Clinical implications of p53 alterations in oral cancer progression: a review from India / K. R. Patel [та ін.]. - С.10-18. - Bibliogr. at the end of the art.
Другие авторы: Vajaria B. N., Singh R. D., Begum R., Patel P. S.
Varela-Castillo, O. Characterization of the cytotoxic effects of the combination of cisplatin and flavanol (-)-epicatechin on human lung cancer cell line A549. An isobolographic approach / O. Varela-Castillo [та ін.]. - С.19-23. - Bibliogr. at the end of the art.
Другие авторы: Cordero P., Gutierrez-Iglesias G., Palma I., Rubio-Gayosso I., Meaney E., Ramirez-Sanchez I., Villarreal F., Ceballos G., Najera N.
Chaves, K. C. B. Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma / K. C. B. Chaves [та ін.]. - С.24-32. - Bibliogr. at the end of the art.
Другие авторы: Costa E. M., Teixeira L. F., Bellini M. H.
Sarnatskaya, V. V. Highly activated carbon enterosorbent mediates the suppression of paraneoplastic syndrome associated with lewis lung carcinoma in mice / V. V. Sarnatskaya [та ін.]. - С.33-41. - Bibliogr. at the end of the art.
Другие авторы: Sakhno L. A., Paziuk L. M., Yushko L. A., Rodionova N. K., Maslenny V. N., Sydorenko A. S., Nikolaev V.G.
Boroday, N. V. Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells / N. V. Boroday, V. F. Chekhun. - С.42-47. - Bibliogr. at the end of the art.
Kurtenkov, O. Signatures of anti-Thomsen — friedenreich antigen antibody diversity in colon cancer patients / O. Kurtenkov, M. Bubina, K. Klaamas. - С.48-58. - Bibliogr. at the end of the art.
Paliychuk, O. V. Molecular-genetic models for prognosis of development of tumors of reproductive system in women with family history of cancer / O. V. Paliychuk [та ін.]. - С.59-67. - Bibliogr. at the end of the art.
Другие авторы: Polishchuk L. Z., Rossokha Z. I., Chekhun V. F.
Buchynska, L. G. Sensitivity to 4-hydroxyestradiol and dna repair efficiency in peripheral blood lymphocytes of endometrial cancer patients / L. G. Buchynska, O. V. Brieieva. - С.68-72. - Bibliogr. at the end of the art.
Lozynska, L. Y. Variant of rare hermansky — pudlak syndrome associated with granulomatous colitis: diagnostics clinical course and treatment / L. Y. Lozynska [та ін.]. - С.73-78. - Bibliogr. at the end of the art.
Другие авторы: Plawski A., Lozynska M. R., Vytvytskyi I., Lozynskyi R. Y., Prokopchuk N., Tretiak B.
Zubenko, O. S. Effect of cytostatic agents on expression levels of human beta-defensins-1-4 in A431 and MCF-7 cell lines / O. S. Zubenko [та ін.]. - С.79-81. - Bibliogr. at the end of the art.
Другие авторы: Semeniuk D. O., Starenka I. O., Pogribnyy P. V.
Imaniar, R. Mediastinal yolk sac tumor infiltrating the heart / R. Imaniar [та ін.]. - С.82-84. - Bibliogr. at the end of the art.
Другие авторы: Syahruddin E., Soepandi P. Z., Putra A. C., Nurwidya F.
Ben, Kridis W. A long survival of a patient with brain metastasis of unknown site of the primary tumor / Kridis W. Ben [та ін.]. - С.85-87. - Bibliogr. at the end of the art.
Другие авторы: Sghaier S., Toumi N., Boudawara Z., Khanfir A., Daoud J., Frikha M.
Symposium and Summer School “Fundamental principles of cancer biotherapy” Kyiv Ukraine May 21-24 2018. - С.88
Имеются экземпляры в отделах: всего 1
Свободны: 1

Найти похожие
Перейти к описаниям статей

13.

Buchynska, L. G.
Sensitivity to 4-hydroxyestradiol and dna repair efficiency in peripheral blood lymphocytes of endometrial cancer patients [Текст] / L. G. Buchynska, O. V. Brieieva // Экспериментальная онкология. - 2018. - Т. 40, № 1. - С. 68-72. - Bibliogr. at the end of the art.

MeSH-главная:
НОВООБРАЗОВАНИЯ ГОРМОНОЗАВИСИМЫЕ -- NEOPLASMS, HORMONE-DEPENDENT (диагностика, патофизиология, этиология)
КАРЦИНОМА ЭНДОМЕТРИОИДНАЯ -- CARCINOMA, ENDOMETRIOID (патофизиология, этиология)
ЛИМФОЦИТЫ -- LYMPHOCYTES (цитология)
ДНК ПОВРЕЖДЕНИЕ -- DNA DAMAGE
РИСКА СТЕПЕНИ ОЦЕНКА -- RISK ADJUSTMENT (статистика, тенденции)
СТАТИСТИЧЕСКАЯ ОБРАБОТКА ДАННЫХ -- DATA INTERPRETATION, STATISTICAL
Аннотация: The development of hormone-dependent cancers, including endometrial carcinomas, in great part may be mediated by the genotoxic effects of estrogen metabolites, among which 4-hydroxyestradiol (4OHE2) is characterized by the most prominent DNA-damaging properties. It is assumed that the individual sensitivity to the 4OHE2 may determine the predisposition to endometrial cancer (EС). Aim: To analyze the sensitivity of peripheral blood lymphocytes (PBLs) of EC patients to the 4OHE2 and to evaluate the repair efficiency of 4OHE2-induced DNA damage. Materials and Methods: The study was performed on the PBLs of 53 EC patients and 20 healthy women. The level of DNA damage was measured using the comet assay and was expressed as % tail DNA. The DNA repair efficiency (%) was evaluated by determining the ratio between the amount of repaired DNA damage and the level of 4OHE2-induced damage that appeared after incubation of PBLs with 4OHE2. Results: In PBLs of EC patients, a higher level of 4OHE2-induced DNA damage (32.0 ± 2.2% tail DNA) and lower DNA repair efficiency (34.0 ± 4.5%) was observed compared to PBLs of healthy women (22.3 ± 2.3% tail DNA and 48.8 ± 4.5%, respectively). PBLs of EC patients with deep tumor invasion of myometrium were characterized by more prominent decrease of DNA repair than those with less invasive tumor ( ½ of myometrium) (20.9 ± 7.8 and 43.7 ± 6.7%, respectively). Furthermore, lower DNA repair efficiency was detected in the PBLs of EC patients with a family history of cancer compared to this parameter in patients with sporadic tumors (20.9±7.8 and 47.1 ± 5.5%, respectively). Conclusion: The PBLs of EC patients are characterized by increased sensitivity to the genotoxic effect of 4OHE2 and reduced repair efficiency regarding 4OHE2-induced DNA damage. A lower level of DNA repair is observed in EC patients with deep tumor myometrial invasion and a family history of cancer
Доп.точки доступа:
Brieieva, O. V.

Свободных экз. нет

Найти похожие

14.

Шифр: ЕУ12/2018/40/3
Журнал

Экспериментальная онкология [Текст]
2018г. Т. 40 № 3

Содержание:
Akbarzadeh, A. Role of dendrimers in advanced drug delivery and biomedical applications: a review / A. Akbarzadeh [та ін.]. - С.178-183. - Bibliogr. at the end of the art.
Другие авторы: Khalilov R., Mostafavi E., Annabi N., Abasi E., Kafshdooz T., Herizchi R., Kavetskyy T., Saghfi S., Nasibova A., Davaran S.
Zadvornyi, T. V. Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro / T. V. Zadvornyi [та ін.]. - С.184-189. - Bibliogr. at the end of the art.
Другие авторы: Lukianova N. Y., Borikun T. V., Chekhun V. F.
Harper, P. The impact of morphine treatment on bladder cancer cell proliferation and apoptosis: in vitro studies / P. Harper [та ін.]. - С.190-193. - Bibliogr. at the end of the art.
Другие авторы: Hald O., Lwaleed B. A., Kyyaly A., Johnston D., Cooper A. J., Birch B.
Apykhtina, О. L. Cytotoxic and genotoxic effects of cadmium sulfide nanoparticles / О. L. Apykhtina [та ін.]. - С.194-199. - Bibliogr. at the end of the art.
Другие авторы: Dybkova S. M., Sokurenko L. M., Chaikovsky Yu. B.
Chekhun, V. F. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats / V. F. Chekhun [та ін.]. - С.200-204. - Bibliogr. at the end of the art.
Другие авторы: Storchai D. M., Todor I. N., Borikun T. V., Lukianova N. Yu.
Prokhorova, I. V. Influence of metformin, sodium dichloroacetate and their combination on the hematological and biochemical blood parameters of rats with gliomas C6 / I. V. Prokhorova [та ін.]. - С.205-210. - Bibliogr. at the end of the art.
Другие авторы: Pyaskovskaya O. N., Kolesnik D. L., Solyanik G. I.
Abramenko, I. V. Analysis of the 3′UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients / I. V. Abramenko [та ін.]. - С.211-217. - Bibliogr. at the end of the art.
Другие авторы: Bilous N. I. , Chumak A. A., Dyagil I. S., Martina Z. V.
Nesina, I. P. Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma / I. P. Nesina, N. P. Iurchenko, L. G. Buchynska. - С.218-222. - Bibliogr. at the end of the art.
Vernygorodskyi, S. Comparative histochemical evaluation of mucins expression in fetal esophagus and adenocarcinomas of the gastroesophageal junction / S. Vernygorodskyi, T. Rekun, P. Zhuchenko. - С.223-227. - Bibliogr. at the end of the art.
Gerashchenko, T. S. Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles / T. S. Gerashchenko [та ін.]. - С.228-234. - Bibliogr. at the end of the art.
Другие авторы: Denisov E. V., Novikov N. M., Tashireva L. A., Kaigorodova E. V., Savelieva O. E., Zavyalova M. V., Cherdyntseva N. V., Perelmuter V. M.
Agishev, T. T. Determination of oxygen perfusion in the area of radiation-induced fibrosis of the skin in patients with breast cancer and its role in pathogenesis of late radiation injury / T. T. Agishev [та ін.]. - С.235-238. - Bibliogr. at the end of the art.
Другие авторы: Topuzov E. E., Кrasnozhon D. A., Petrachkov A. O., Pavlov R. V., Doniyarov S. H.
Dumansky, Yu. V. Paraneoplastic syndrome in lung cancer / Yu. V. Dumansky [та ін.]. - С.239-242. - Bibliogr. at the end of the art.
Другие авторы: Syniachenko O. V., Stepko P. A., Yehudina Ye. D., Stoliarova O. Yu.
Grybach, S. M. Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome / S. M. Grybach, L. Z. Polishchuk, V. F. Chekhun. - С.243-248. - Bibliogr. at the end of the art.
Chrysanthakopoulos, N. A. ABO blood group and the risk of lung cancer in Greek adults: a case — control study / N. A. Chrysanthakopoulos, N. S. Dareioti. - С.249-250. - Bibliogr. at the end of the art.
Tkachenko, R. A case report of late local relapse of adrenocortical carcinoma 18 years after adrenalectomy / R. Tkachenko, A. Golovko, O. Kuryk. - С.251-253
Svitlana Pavlivna Sidorenko (1953–2018). - С.254-255
Yurii Yosypovych Kudryavets (1946–2018). - С.256-257
Имеются экземпляры в отделах: всего 1
Свободны: 1

Найти похожие
Перейти к описаниям статей

15.

Nesina, I. P.
Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma [Текст] / I. P. Nesina, N. P. Iurchenko, L. G. Buchynska // Экспериментальная онкология. - 2018. - Т. 40, № 3. - С. 218-222. - Bibliogr. at the end of the art.

MeSH-главная:
ЭНДОМЕТРИЯ НОВООБРАЗОВАНИЯ -- ENDOMETRIAL NEOPLASMS (диагностика, патофизиология, этиология)
КЛЕТКИ ПРОЛИФЕРАЦИЯ -- CELL PROLIFERATION
КАДГЕРИНЫ -- CADHERINS (анализ, диагностическое применение)
БЕТА-КАТЕНИН -- BETA CATENIN (анализ, диагностическое применение)
ВИМЕНТИН -- VIMENTIN (анализ, диагностическое применение)
ИММУНОГИСТОХИМИЯ -- IMMUNOHISTOCHEMISTRY (использование, статистика)
СТАТИСТИЧЕСКАЯ ОБРАБОТКА ДАННЫХ -- DATA INTERPRETATION, STATISTICAL
ФОТОГРАФИЧЕСКИЕ СНИМКИ -- PHOTOGRAPHS
Аннотация: To study the expression of adhesion markers (E-cadherin, β-catenin and vimentin) associated with epithelial-mesenchymal transition (EMT) and their role in progression of endometrial carcinoma (EC). Materials and Methods: Expression of E-cadherin, β-catenin and vimentin was studied immunohistochemically in the samples of surgical material of 55 EC patients stage I–III. The proliferation index was determined by flow cytometry. Results: In the group of vimentin-negative EC, tumors of low differentiation grade and deep invasion in myometrium as well as high expression of E-cadherin and β-catenin prevailed compared with the cases with high expression of vimentin. In addition, in EC with high expression of vimentin, an increase in the number of cells with expression of E-cadherin in the cytoplasm (78.9 ± 3.6%) and β-catenin with cytoplasmic-nuclear localization (73.7 ± 3.2%) was observed compared with these indices in vimentin-negative tumors (45.4 ± 4.2%, p 0.001 and 54.5 ± 2.6%, respectively, p 0.005), which may indicate EMT-associated changes in EC with high expression of vimentin. Conclusions: The progression of the endometrioid carcinoma may occur in the setting of various molecular changes, in particular, with decreased expression of E-cadherin and β-catenin and high expression of vimentin, or in the absence of vimentin, utilizing other mechanisms of regulation of proliferative and metastatic potential. Key Words: endometrial cancer, proliferation index, E-cadherin, β-catenin, vimentin
Доп.точки доступа:
Iurchenko, N. P.
Buchynska, L. G.

Свободных экз. нет

Найти похожие

16.

Шифр: ЕУ12/2019/41/2
Журнал

Экспериментальная онкология [Текст]
2019г. Т. 41 № 2 . - 45.41, р.

Содержание:
Verma, S. Evaluating the role of dithiolane rich fraction of Ferula asafoetida (apiaceae) for its antiproliferative and apoptotic properties: in vitro studies / S. Verma [та ін.]. - С.90-94. - Bibliogr. at the end of the art.
Другие авторы: Khambhala P., Joshi S., Kothari V., Patel T., Seshadri S.
Syvyk, A. E. Inducible dominant negative ErbB2 rat spermatogonial line for generation of transgenic rat model and dissecting ERBB2 tyrosine kinase mediated pathways / A. E. Syvyk, T. L. Syvyk. - С.95-105. - Bibliogr. at the end of the art.
Prylutska, S. V. Antitumor effects and hematotoxicity of C60-Cis-Pt nanocomplex in mice with Lewis lung carcinoma / S. V. Prylutska [та ін.]. - С.106-111. - Bibliogr. at the end of the art.
Другие авторы: Lynchak O. V., Kostjukov V. V., Evstigneev M. P., Remeniak O. V., Rybalchenko V. K., Prylutskyy Yu. I., Ritter U., Scharff P.
Petrellis, M. C. Proinflammatory effects of photoactivated methylene blue on rat model of Walker 256 carcinosarcoma / M. C. Petrellis [та ін.]. - С.112-122. - Bibliogr. at the end of the art.
Другие авторы: Frigo L., Ribeiro W., Leal-Junior E. C. P., Oliveira F. R., Maria D. A., Lopes-Martins R. Á. B.
Kolesnik, D. L. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6 / D. L. Kolesnik [та ін.]. - С.123-129. - Bibliogr. at the end of the art.
Другие авторы: Pyaskovskaya O. N., Yurchenko O. V., Solyanik G. I.
Herrera-Covarrubias, D. Prepuberal stress and obesity: effects on serum corticosterone, prolactin, testosterone and precancerous prostate lesions in adult rats / D. Herrera-Covarrubias [та ін.]. - С.130-137. - Bibliogr. at the end of the art.
Другие авторы: Coria-Avila G. A., Aranda-Abreu G. E., Manzo J., Hernández M. E.
Buchynska, L. G. Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas / L. G. Buchynska, O. V. Brieiev, N. P. Iurchenko. - С.138-143. - Bibliogr. at the end of the art.
Kravets, O. V. Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma / O. V. Kravets [та ін.]. - С.144-147. - Bibliogr. at the end of the art.
Другие авторы: Protsyk V. S., Burtyn O. V., Hlynin O. V., Hurianov V. H.
Burlaka, A. P. Tumor-associated redox state in metastatic colorectal cancer / A. P. Burlaka [та ін.]. - С.148-152. - Bibliogr. at the end of the art.
Другие авторы: Ganusevich I. I., Burlaka A. A., Virko S. V., Kolesnik О. О.
Tajaldeen, A. Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi / A. Tajaldeen, S. Alghamdi. - С.153-159. - Bibliogr. at the end of the art.
Yakovlev, P. G. Bladder sparing surgery in high-grade bladder cancer / P. G. Yakovlev, D. A. Klyushin, R. I. Vereshchako. - С.160-165. - Bibliogr. at the end of the art.
Cešeiko, R. The impact of maximal strength training on quality of life among women with breast cancer undergoing treatment / R. Cešeiko [та ін.]. - С.166-172. - Bibliogr. at the end of the art.
Другие авторы: Eglītis J., Srebnijs A., Timofejevs M., Purmalis E., Erts R., Vētra A., Tomsone S.
Ben, Kridis W. Prognostic factors in metastatic gastric carcinoma / Kridis W. Ben [та ін.]. - С.173-175. - Bibliogr. at the end of the art.
Другие авторы: Marrekchi G., Mzali R., Daoud J., Khanfir A.
Dumanskiy, Y. V. The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer / Y. V. Dumanskiy, O. V. Bondar, E. A. Stoliarchuk. - С.176-178. - Bibliogr. at the end of the art.
Starchenko, I. I. The observation of congenital retroperitoneal large size neuroblastoma / I. I. Starchenko [та ін.]. - С.179-181. - Bibliogr. at the end of the art.
Другие авторы: Dyachenko L. V., Prylutskyi O. K., Vynnyk N. I., Filenko B. M.
Ben, Kridis W. Buschke — Lowenstein anal tumor: an ambiguous entity / Kridis W. Ben [та ін.]. - С.182-184. - Bibliogr. at the end of the art.
Другие авторы: Werda I., Charfi S., Toumi N., Boudawara T., Mzali R., Daoud J., Khanfir A.
Имеются экземпляры в отделах: всего 1
Свободны: 1

Найти похожие
Перейти к описаниям статей

17.

Buchynska, L. G.
Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas [Текст] / L. G. Buchynska, O. V. Brieiev, N. P. Iurchenko // Экспериментальная онкология. - 2019. - Т. 41, № 2. - С. 138-143. - Bibliogr. at the end of the art.

Аннотация: To analyze copy number variations of HER-2/neu, c-MYC and CCNE1 oncogenes and their protein expression in endometrioid endometrial carcinomas in relation to the degree of tumor progression and presence of a family history of cancer in cancer patients. Materials and Methods: The study was conducted on endometrial cancer (EC) samples from 68 patients with I–II FIGO stages of disease. Copy number analysis of HER-2/neu, c-MYC and CCNE1 genes was performed by quantitative PCR. Protein expression was analyzed using immunohistochemistry. Results: Assessment of copy number variations of HER-2/neu, c-MYC and CCNE1 genes revealed their amplification in the tumors of 18.8, 25.0 and 14.3% of EC patients, respectively. High expression of corresponding proteins was detected in 14.6, 23.5 and 65.6% of patients, respectively. It was established that HER-2/neu gene amplification is more common in the group of tumors of low differentiation grade than in moderate grade EC (35.7 and 5.5% of cases, respectively, p 0.05). Also, high expression of c-Myc protein was more frequently observed in low differentiated tumors compared to the moderately differentiated EC (36.6 and 13.2% of cases, respectively, p 0.05). Expression of HER-2/neu and cyclin E proteins was found to be dependent on the depth of tumor invasion into the myometrium. High expression of HER-2/neu protein was observed in 25.0 and 4.1% of EC patients with tumor invasion ½ and ½ of the myometrium, respectively, and cyclin E — in 86.7 and 46.6% of cases, respectively, p 0.05. It was shown that among patients with a family history of cancer, a larger proportion of cases with high expression of c-Myc protein was observed compared to the group of patients with sporadic tumors (43.8 and 17.3%, respectively; p 0.05). Conclusions: Amplification of HER-2/neu gene, along with high expression of c-Myc, HER-2/neu and cyclin E proteins, are associated with such indices of tumor progression as a low differentiation grade and deep myometrial invasion, suggesting the potential possibility of including these markers in the panel for determining the molecular EC subtype associated with an aggressive course of the disease. In a certain category of EC patients, there is a relationship between a family history of cancer and high expression of c-Myc protein
Доп.точки доступа:
Brieiev, O. V.
Iurchenko, N. P.

Свободных экз. нет

Найти похожие

18.

Шифр: ЕУ12/2020/42/4
Журнал

Экспериментальная онкология [Текст]
2020г. Т. 42 № 4 . - 51.52, р.

Содержание:
Commitment to ideals of science. To the 90th birthday anniversary of academician Vadym Pinchuk. - С.250-251
Naleskina, L. A. Modern views on the role of main components of stroma and tumor microinvironment in invasion, migration and metastasis / L. A. Naleskina, L. M. Kunska, V. F. Chekhun. - С.252-262. - Бібліогр.: в кінці ст.
Gaptulbarova, K. A. NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer / K. A. Gaptulbarova [та ін.]. - С.263-269. - Бібліогр.: в кінці ст.
Другие авторы: Tsyganov M. M., Pevzner A. M., Ibragimova M. K., Litviakov N. V.
Tykhomyrov, A. A. Plasminogen/plasmin affects expression of glycolysis regulator TIGAR and induces autophagy in lung adenocarcinoma A549 cells / A. A. Tykhomyrov [та ін.]. - С.270-276. - Бібліогр.: в кінці ст.
Другие авторы: Nedzvetsky V. S., Aĝca C. A., Guzyk M. M., Korsa V. V., Grinenko T. V.
Kumar, A. Microarray based gene expression profiling of advanced gall bladder cancer / A. Kumar [та ін.]. - С.277-284. - Бібліогр.: в кінці ст.
Другие авторы: Gupta R., Mathur N., Iyer V. K., Thulkar S., Prasad C. P., Das P., Rani L., Maqbool M., Shukla N. K., Pal S., Sundar D., Sharma A.
Auziņa, D. Dickkopf-related protein 1 expression in bone marrow of multiple myeloma patients: correlation with bone disease and plasma cell malignancy type / D. Auziņa [та ін.]. - С.285-288. - Бібліогр.: в кінці ст.
Другие авторы: Beinaroviča I., Janicka-Kupra B., Lejniece S., Lejnieks A., Groma V.
Buchynska, L. G. Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium / L. G. Buchynska [та ін.]. - С.289-294. - Бібліогр.: в кінці ст.
Другие авторы: Borykun T. V., Iurchenko N. P., Nespryadko S. V., Nesina I. P.
Kovalevska, L. Expression pattern of MRPS18 family genes in malignantly transformed b-cells / L. Kovalevska, E. Kashuba. - С.295-299. - Бібліогр.: в кінці ст.
Buchynska, L. G. Molecular phenotype of high-grade endometrioid carcinoma of the endometrium / L. G. Buchynska [та ін.]. - С.300-305. - Бібліогр.: в кінці ст.
Другие авторы: Glushchenko N. M., Nesina I. P., Brieieva O. V., Iurchenko N. P.
Shamrai, D. Granulosa and theca cell tumor in rat’s ovary after modified Biskind operation / D. Shamrai, E. Koshik, N. Melnyk. - С.306-309. - Бібліогр.: в кінці ст.
Bolgova, L. S. Histogenesis of central lung cancer: cytological investigation / L. S. Bolgova [та ін.]. - С.310-313. - Бібліогр.: в кінці ст.
Другие авторы: Tuganova T. N., Alekseenko O. I., Litvinets O. M., Suprun G. A., Ponomarenko A. A.
Shcherbynina, M. Histological criteria for “intraepithelial squamous cell carcinoma” of the esophagus: continued dialogue between Ukrainian and Japanese pathologists / M. Shcherbynina, M. Itabashi, N. Soloviova. - С.314-317. - Бібліогр.: в кінці ст.
Yevstakhevych, Yu. L. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment / Yu. L. Yevstakhevych [та ін.]. - С.318-323. - Бібліогр.: в кінці ст.
Другие авторы: Vyhovska Ya. I., Yevstakhevyc I. Y., Vyhovsk O. Y., Pelenyo N. V., Semerak M. M., Novak V. L., Loginsky V. E.
Korovin, S. Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival / S. Korovin [та ін.]. - С.324-329. - Бібліогр.: в кінці ст.
Другие авторы: Fedorenko Z., Michailovich Yu., Kukushkina M., Sekerija M., Ryzhov A.
Burlaka, A. P. Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer / A. P. Burlaka [та ін.]. - С.330-332. - Бібліогр.: в кінці ст.
Другие авторы: Virko S. V., Burlaka A. A., Chernobai V. А., Yatsyna O. I., Ganusevich I. I.
Kitsera, N. Woman with Turner syndrome and her child with acute leukemia (a case report) / N. Kitsera, O. Dorosh, H. Makukh. - С.333-336. - Бібліогр.: в кінці ст.
Buchatskyi, L. P. Hypoxia induces melanotic pseudotumors in the larvae of mosquitoes of Culicidae family / L. P. Buchatskyi. - С.337. - Бібліогр.: в кінці ст.
Mykola Oleksandrovych Druzhyna (1940–2020). - С.338
Имеются экземпляры в отделах: всего 1
Свободны: 1

Найти похожие
Перейти к описаниям статей

19.

Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium [Текст] / L. G. Buchynska [та ін.] // Экспериментальная онкология. - 2020. - Т. 42, № 4. - С. 289-294. - Бібліогр.: в кінці ст.

Аннотация: It is known that more than half of the genes encoding human proteins are regulated by various microRNAs (miRNAs, miR), the expression of which may be associated with various pathological conditions. At the same time, the question of assessing the relationship between the expression of particular miRNAs and the aggressive molecular subtype of endometrial cancer remains open. Aim of the study was to determine the relationship between the expression of miR-34a, miR-125b, miR-142 and miR-101 in endometrioid carcinomas of the endometrium (ECE) and the features of the disease course. Materials and Methods: The samples of surgical material of 51 patients with ECE (mean age 59.8 ± 7.1 years), I–III stage were investigated using morphological, immunohistochemical methods, real time polymerase chain reaction (PCR), cytofluorometry. Results: In endometrial tumors with high proliferation index ( Me), the expression of miR-34a, miR-142 and miR-125b significantly decreased (1.8, 2.7 and 1.5 times, respectively) compared with those in ECE with low proliferation index ( Me). The expression of all studied miRNAs was lower in G3 tumors and those that deeply invaded the myometrium compared to G2 carcinomas and tumors with an invasion of 1/2 myometrium and significantly decreased in tumors of patients with low stage III compared with stage I–II. The high ( Me) microvessel density in ECE was associated with a significant decrease of miR-125b and miR-101 expression, and the presence of signs of epithelial-mesenchymal transition — with a decreased expression of miR-34a and miR-101. Conclusions: The study revealed a significant heterogeneity of expression of miR-34a, miR-125b, miR-142 and miR-101 in ECE, which is associated with changes in morphofunctional characteristics of endometrial carcinoma
Доп.точки доступа:
Buchynska, L. G.
Borykun, T. V.
Iurchenko, N. P.
Nespryadko, S. V.
Nesina, I. P.

Свободных экз. нет

Найти похожие

20.

Molecular phenotype of high-grade endometrioid carcinoma of the endometrium [Текст] / L. G. Buchynska [та ін.] // Экспериментальная онкология. - 2020. - Т. 42, № 4. - С. 300-305. - Бібліогр.: в кінці ст.

Аннотация: Prognosis of the course of tumor progression is one of urgent problems of clinical oncology. A relevant specificity of endometrial cancer is its clinical polymorphism within the same histological type of the disease. The search for molecular-biological features associated with the aggressive phenotype of endometrioid carcinomas is indisputably urgent. Aim: To study molecular-biological features of endometrioid carcinoma of the endometrium (ECE) and to identify the molecular subtype of tumors with high potential of malignancy. Materials and Methods: Surgical specimens of 127 patients with EC, stages I–II, aged 36–72 (the average age — 59.3 ± 3.2) were studied using morphological and immunohistochemical methods. The multivariant analysis with the Kullback’s informative measure and PanelomiX were used to estimate the significance of the expression of specific biomarkers. Results: The expression of a complex of multifunctional markers was evaluated in ECE cells of different malignancy stage: p53, FOXP3, p21WAF1/CIP1, р16INK4a, E2F1, cyclins Е and D1, Her2/neu, с-Myc, Е-cadherin, β-catenin, vimentin, CD44, CD24. A triad of biomarkers with threshold expression levels was determined (р53 45%; FOXP3 14%; с-Myc 10%). The high expression of oncogene c-Myc and oncosuppressor p53 along with the low level of FOXP3 in tumor cells of ECE was associated with high proliferative potential, low differentiation grade, and deep invasion of a tumor into the myometrium. Conclusions: The molecular phenotype of ECE, most informative in terms of specificity and sensitivity (95%) — р53highFOXP3lowc-Mychigh, was first characterized, which would help identify a high-grade subtype of this cancer form
Доп.точки доступа:
Buchynska, L. G.
Glushchenko, N. M.
Nesina, I. P.
Brieieva, O. V.
Iurchenko, N. P.

Свободных экз. нет

Найти похожие

Тематический навигатор

Статистика обращений

© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)